BMSC‐EV‐derived lncRNA NORAD Facilitates Migration, Invasion, and Angiogenesis in Osteosarcoma Cells by Regulating CREBBP via Delivery of miR‐877‐3p
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 8825784
Abstract
Bone marrow mesenchymal stem cells (BMSCs) can boost osteosarcoma (OS) cell proliferation and invasion, yet the function of extracellular vesicles (EVs) derived from BMSCs on OS is scarcely known. This study is aimed at examining the role of BMSC‐EVs in OS cells. BMSCs and BMSC‐EVs were isolated and identified. The effect of EVs and EVs‐si‐NORAD on OS cell proliferation, invasion, migration, and angiogenesis was determined. Expressions of NORAD, miR‐877‐3p, and CREBBP were detected. The binding relationship among NORAD, miR‐877‐3p, and CREBBP was verified. The miR‐877‐3p inhibitor or pc‐CREBBP was delivered into OS cells treated with EVs‐si‐NORAD for in vitro analysis. The nude mouse model of the subcutaneous tumor xenograft was established for in vivo analysis. BMSC‐EVs promoted OS cell proliferation, invasion, migration, and angiogenesis. BMSC‐EVs carried NORAD into OS cells and upregulated CREBBP by sponging miR‐877‐3p. miR‐877‐3p downregulation or CREBBP overexpression partly inverted the inhibitory effect of EVs by silencing NORAD on OS cell proliferation, invasion, migration, and angiogenesis. In vivo experiments validated that BMSC‐EV‐derived NORAD facilitated tumor growth by upregulating CREBBP via miR‐877‐3p. To conclude, BMSC‐EV‐derived NORAD facilitated OS cell proliferation, invasion, migration, and angiogenesis by modulating CREBBP via miR‐877‐3p, which may offer new insights into OS treatment.Keywords
This publication has 39 references indexed in Scilit:
- Early Lymphocyte Recovery and Outcome in OsteosarcomaJournal of Pediatric Hematology/Oncology, 2017
- Cancer stem cells in osteosarcomaCancer Letters, 2017
- Long noncoding RNAs in cancer: mechanisms of action and technological advancementsMolecular Cancer, 2016
- Long Noncoding RNAs in Cancer PathwaysCancer Cell, 2016
- Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and DiseaseInternational Journal of Molecular Sciences, 2016
- Long Noncoding RNAs in Cancer: From Function to TranslationTrends in Cancer, 2015
- Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensingJournal of Thrombosis and Haemostasis, 2014
- Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcomaActa Oncologica, 2014
- BASI, A Potent Small Molecular Inhibitor, Inhibits Glioblastoma Progression by Targeting microRNA‐mediated β‐Catenin SignalingCNS Neuroscience & Therapeutics, 2014
- Array-based comparative genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumorsJournal of Experimental & Clinical Cancer Research, 2012